Duterte honors wounded, slain cops in CamSur ambush

admin   •   October 24, 2018   •   3679

President Rodrigo Roa Duterte commiserates with the relatives of one of the slain police officers during his visit at the Camarines Sur Provincial Police Office in Naga City on October 23, 2018. SIMEON CELI JR./PRESIDENTIAL PHOT

President Duterte went to Camarines Sur on Tuesday (October 23) where he visited the three policemen who were wounded in the ambush against the convoy of Food and Drug Administration (FDA) Director General Nela Charade Puno in Brgy. Napolidad, Lupi, Camarines Sur last October 18.

The President bestowed the Order of Lapu-Lapu with rank of Kampilan to the three injured cops.

The Kampilan is awarded to government personnel and private individuals who were seriously wounded while carrying out activities related to the President’s advocacy.

Duterte also personally sent condolences to the families of the three other cops who died in the incident, namely, SPO1 Percival Rafael Jr. PO3 Carlito Navaroza Jr. and PO1 Ralph Jason Vida.

He visited the wake of PO1 Vida in Camarines Sur Provincial Police Office and awarded him the Order of Lapu-Lapu with the rank of Kalasag.

Kalasag is given to officials, government personnel and private individuals who lost their lives as a direct result of their participation in tasks pursuant to a campaign or advocacy of the President.

Duterte was joined by FDA Director General Puno whom the wounded police personnel were escorting the day of the incident.

“Maraming maraming salamat sa lahat ng mga nagligtas ng buhay ng Team FDA. Sa mga pulis na nasaktan at mga pulis na namatay, nakakagalit. Si Presidente po ay siguradong hindi papayagan na ganito lang ang mangyari,” said Puno.

President Duterte did not provide any statement to the media, however, Philippine Army 9TH Infantry Battalion Division commanding general MGen. Jesus Manangquil said that Duterte has instructed the Philippine Army and Philippine National Police to intensify the localized peace talks with the New People’s Army, who are responsible for the ambush.

“Nanawagan pa rin ulit kami sa mga nandirito na gumagala sa bundok na mag-usap, mapag-usapan through localized dialogue o peace initiative. Lalong lalo na napakaganda ng iminumungkahi ng ating gobyerno with the package na may pabahay na worth 450,000 na pabahay sa mga mag-susurender na NPA,” said the commanding general. — Yssa Jalmasco (with reports from Allan Manansala)

Show-cause order issued to FDA drug center for alleged inaction on over 600 applications

Marje Pelayo   •   May 12, 2021

MANILA, Philippines – The Anti-Red Tape Authority (ARTA) has issued a show-cause order to the Food and Drug Administration (FDA) Center for Drug Regulation and Research (CDRR) for allegedly not acting on over 600 drug applications despite having complete requirements.

The order, sent on Tuesday (May 11) by ARTA Investigation Enforcement and Litigation Director Jedrek Ng, directs FDA-CDRR Director IV Jesusa Cirunay  to “explain why no administrative or criminal case should be filed” against her over delays in applications of various pharmaceutical companies filed as far back as 2014 or so.

“Pag titingnan po ito ang mga applications na ‘to di ito kumplikado. Ito yung mga aplikasyong for automatic renewal. Ito ay mga produkto na dati nang ginagamit at ngayon ay gusto lang i-register o yung iba naman ay low to no risk sa taumbayan,” ARTA director general Jeremiah Belgica said.

“Di namin maintidihan kung bakit ito ay naiipit at ito ay palagi na nangyayari diyan sa FDA particularly sa Center for Drugs. Ito ay mga aplikasyon na pwedeng aprubahan ng center director,” he added.

Cirunay is given seven working days from receipt of the order to conduct an inventory of all pending permit, license, clearance or application; immediately release all said applications which have been pending beyond the prescribed processing time.

Also, she is directed to submit to ARTA a compliance report with a list of all permits, licenses, clearances or applications issued pursuant to the show cause order.

If Cirunay fails to comply, ARTA will resort to the filing of formal charges against her in accordance with Republic Act No. 11032 or the Ease of Doing Business and Efficient Government Service Delivery law before the Office of the Ombudsman.

Belgica also urged Health Secretary Francisco Duque III and FDA Director General Eric Domingo to remove, if necessary, their erring officials and personnel.

Evaluation of EUA application for Sinopharm vax may be completed in less than 21 days – FDA

Robie de Guzman   •   May 11, 2021

MANILA, Philippines – The evaluation process for the Sinopharm COVID-19 vaccine will not take long before it can be granted an emergency use authorization (EUA) in the Philippines, the Food and Drug Administration (FDA) said Tuesday.

FDA director-general Eric Domingo said the Sinopharm vaccine has already been included in the emergency use listing (EUL) of the World Health Organization (WHO) and access to its documents, including inspection reports from the WHO will be faster.

“Useful yung kanyang Emergency Use Listing sa WHO kasi before this, wala pa siyang EUA from a stringent regulatory authority katulad ng mga USFDA ganyan or Europe, Japan… hindi pa siya listed sa mga iyon. Pero yung WHO na emergency use listing that’s equivalent to a stringent regulatory authority,” he said.

“Ang maganda sa WHO kasi very transparent ang documents nyan. Available din siya sa FDA. Lahat ng ni-review nila, maaari naming ma-access kaya hindi tayo masyado mahihirapan sa paghingi ng information,” he added.

The Department of Health (DOH) earlier said it has started the process of applying for EUA, pending documents about the vaccine product.

The FDA said the process may take less than 21 days once the DOH completes the application process.

“Kapag ganyan na merong WHO EUL, mas mapapabilis iyan. Nakakaya natin iyan usually less than 21 days,” Domingo said.

The FDA also echoed the DOH’s earlier statement that there are no irregularities with the government’s move to file an EUA for a Chinese-made vaccine since they also applied for the EUA of other COVID-19 vaccine brands, such as Sinovac, AstraZeneca, and Pfizer, in order for these vaccines to be delivered to the country.

“Talagang nasa batas and it’s a worldwide practice,” he said. “Based on WHO guidelines, posible naman na gobyerno gusto bumili ng bakuna na walang local manufacturer or representative dito. In those cases, the government itself can get EUA.”

“Hindi naman conflict yun dahil ang EUA ay hindi naman product registration o marketing authorization lang, talagang for emergency use lang ang mga bakuna,” he added. – RRD (with details from Correspondent Aiko Miguel)

DOH studying possibility of mixing vaccine brands – FDA

Robie de Guzman   •   May 6, 2021

MANILA, Philippines – The Department of Health (DOH) is currently looking into the possibility of mixing different brands of vaccines against novel coronavirus disease (COVID-19), the Food and Drug Administration (FDA) said Thursday.

FDA director general Eric Domingo said the DOH is already drafting a set of guidelines that will allow a person to receive different brands of COVID-19 vaccines for first and second doses in case of severe allergic reaction and other adverse effects.

Aaralin po ngayon yan ng Department of Health, in fact, meron naman po talagang ongoing meetings ang Department of Health on that dahil meron po talagang instances na for example naturukan ka ng bakuna ng first dose tapos nagka-severe allergy ka so hindi ka na puwede sa second dose nun at kailangang isipin ngayon yung magiging alternative,” Domingo said during the Laging Handa briefing.

“Gumagawa na ng guidelines ngayon ang DOH kung paano ‘yung interchangeability or mixing ng vaccines in case the second dose cannot be given na identical doon sa first dose,” he added.

Domingo said this after President Rodrigo Duterte said he has requested China to recall the 1,000 doses of Sinopharm vaccines it donated following criticisms over his decision to receive a jab that has yet to secure an emergency use authorization from the FDA.

Duterte received his first dose of Sinopharm vaccine on Monday night.

Malacañang earlier said that the vaccine dose used on the president was covered by the compassionate special permit issued by the FDA for the Presidential Security Group.

REACH US

The Philippine Broadcast Hub

UNTV, 915 Barangay Philam,

EDSA, Quezon City M.M. 1104

(+632) 8396-8688 (Tel)

info@untv-newsandrescue.com (General inquiries)

ABOUT UNTV

UNTV is a major TV broadcast network with 24-hour programming. An Ultra High Frequency station with strong brand content that appeal to everyone, UNTV is one of the most trusted and successful Philippine networks that guarantees wholesome and quality viewing experience.